GO
Loading...

Oxycontin Issues

Thursday, 10 May 2007 | 1:12 PM ET

Three drug company executives agree to pay more than $600 million for misleading consumers about Oxycontin's risks, with Mike Huckman, CNBC pharmaceuticals reporter